mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |